Product Images Gabapentin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Gabapentin NDC 60760-818 by St. Mary's Medical Park Pharmacy, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

GABA - GABAPENTIN 60760 818 60

GABA - GABAPENTIN 60760 818 60

This text appears to be a packaging label for Gabapentin capsules, which come in 100mg strength and are manufactured in India by a company called Sllidfiplflm. The capsules have a NDC (National Drug Code) number of 60760-818-60 and are available in quantities of 60. The label includes lot and expiration numbers for the capsules. There are also instructions to use as directed and to store at controlled room temperature.*

formula - ab1e0185 b802 4cf2 a5d4 b71f27f1dcb0 00

formula - ab1e0185 b802 4cf2 a5d4 b71f27f1dcb0 00

This is a formula to calculate the creatinine clearance rate (CLOr) for patients, using their age in years, weight in kilograms, and serum creatinine level in mg/dL. The formula includes adjustments for female patients (0.85 multiplier).*

figure1 - d45f499b 8612 479e 8dd2 4fe28b1f5f9c 01

figure1 - d45f499b 8612 479e 8dd2 4fe28b1f5f9c 01

image 1 - d45f499b 8612 479e 8dd2 4fe28b1f5f9c 02

image 1 - d45f499b 8612 479e 8dd2 4fe28b1f5f9c 02

image 2 - d45f499b 8612 479e 8dd2 4fe28b1f5f9c 03

image 2 - d45f499b 8612 479e 8dd2 4fe28b1f5f9c 03

The text provides information on a 4-week fixed-dose period study, comparing two treatments (one being Gabapentin) to a placebo. The dosage for Gabapentin was 1800mg/day and 2400mg/day, and the study reports mean pain scores over a period of seven time points (baseline, 1-7).*

image 3 - d45f499b 8612 479e 8dd2 4fe28b1f5f9c 04

image 3 - d45f499b 8612 479e 8dd2 4fe28b1f5f9c 04

This is a graph showing the proportion of responders in patients suffering from Postherpetic Neuralgia (PHN) and achieving more than 50% reduction in pain score in controlled studies. The graph includes data from two studies, where study 2 has shown slightly higher response rates than study 1. The text also includes pricing for GBP 3600 for GBP, 1800 for Placebo, and GBP 2400 for an unspecified treatment related to the studies.*

image 4 - d45f499b 8612 479e 8dd2 4fe28b1f5f9c 05

image 4 - d45f499b 8612 479e 8dd2 4fe28b1f5f9c 05

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.